Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China · Delayed Price · Currency is CNY 3.610
+0.040 (1.12%)
Feb 3, 2026, 3:04 PM CST
SHE:300026 Revenue
Tianjin Chase Sun Pharmaceutical Co.,Ltd had revenue of 1.35B CNY in the quarter ending September 30, 2025, a decrease of -6.32%. This brings the company's revenue in the last twelve months to 5.49B, down -2.44% year-over-year. In the year 2024, Tianjin Chase Sun Pharmaceutical Co.,Ltd had annual revenue of 5.78B, down -5.34%.
Revenue (ttm)
5.49B
Revenue Growth
-2.44%
P/S Ratio
1.98
Revenue / Employee
1.04M
Employees
5,297
Market Cap
10.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.78B | -326.09M | -5.34% |
| Dec 31, 2023 | 6.11B | -541.17M | -8.14% |
| Jan 1, 2023 | 6.65B | -1.02B | -13.30% |
| Dec 31, 2021 | 7.67B | 1.18B | 18.22% |
| Dec 31, 2020 | 6.49B | 1.49B | 29.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition